Vanguard Group Inc Arvinas, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,299,556 shares of ARVN stock, worth $209 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,299,556
Previous 4,851,390
29.85%
Holding current value
$209 Million
Previous $200 Million
30.23%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARVN
# of Institutions
234Shares Held
64.9MCall Options Held
119KPut Options Held
94.2K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$223 Million7.92% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$182 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.37MShares$145 Million0.02% of portfolio
-
Rtw Investments, LP New York, NY3.3MShares$109 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$98.9 Million4.76% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.76B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...